Exelon, also known as rivastigmine, is used to improve cognitive ability in patients suffering from Alzheimer's disease. Exelon is manufactured by Novartis Pharmaceuticals.

In January 2001 Novartis issued a statement warning doctors of the risk of severe vomiting and rupture of the esophagus in those patients who stop Exelon treatment for several days and then begin taking the drug again. Doctors should be careful to prescribe the lowest possible dose when reinitiating treatment with Exelon. Eventually the doctor may increase the patient's dose back to the pre-interruption level.

See your doctor if you have experienced serious side effects associated with Exelon. In addition, it may be important to contact an attorney who can help you protect your legal rights. Please keep in mind that there may be time limits within which you must commence suit.



See Also

  1. Alzheimers & Dementia: Overview
  2. Nausea: Overview
  3. Ruptured Esophagus: Overview
  Name Size